Susan Mahony, SVP & President, Lilly Oncology at LILLY ELI & CO (LLY), sold 5,000 shares at $56.00 ($280K) on 2013-03-26, disclosed to the SEC on 2013-03-26.
Scheduled sale ($280k) by SVP & President, Lilly Oncology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| LLY | SELL | 2017-12-05 | $6.3M | — | Filing → |
| LLY | SELL | 2016-12-19 | $2.9M | — | Filing → |
| LLY | SELL | 2015-07-29 | $2.1M | — | Filing → |